Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device
Author(s) -
Michele Massimo Gulizia,
S Mangiameli,
Serafino Orazi,
Giacomo Chiarandà,
Giuseppe Boriani,
Guglielmo Piccione,
Nicolò DiGiovanni,
Andrea Colletti,
Calogero Puntrello,
Gaetano Butera,
Calogero Vasco,
Ignazio Vaccaro,
G. Scardace,
Andrea Grammatico
Publication year - 2006
Publication title -
ep europace
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eul055
Subject(s) - medicine , atrial fibrillation , cardiology , atrial flutter , atrial tachycardia , randomized controlled trial , tachycardia , population , anesthesia , catheter ablation , environmental health
Atrial tachycardia and flutter frequently occur in association with atrial fibrillation and may be treated by overdrive pacing in patients who receive pacemakers with antitachycardia pacing (ATP) capabilities. The PITAGORA trial was a multi-centre, randomized, cross-over study aimed at comparing two different ATP modes for atrial tachyarrhythmia (AT) termination in patients suffering from sinus node disease (SND).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom